6Silverstein FE,Faich G,Goidstein JL,et al.Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis:the CLASS study:a long-term arthritis safety study[J].JAMA,2000,284(10):1247-1255.
7Mamdani M ,Rochon PA ,Junrlink DN,et al .Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs[J].BMJ ,2002,325(7365):624-627.
8Martel-pelletier J,Mccollum R,Fujimono N,et al.Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis[J].Lab invest,1994,70(6):807-815.
9Freemont AJ ,Hampson V ,Tilman R,et al .Gene expression of matrix metalloproteinase 1,3 and 9 by chondrocytes in osteoarthritid human knee articular cartilage is zone and grade specific [J].Ann Rheum Dis,1997,56(9):542-549.
10Mansell JP ,Tarlton JF,Bailey AJ.Biochemical evidence for altered subchondral bone collagen metabolism in osteoarthritis of the hip[J].Br J Rheumatol ,1997,36(1):16-19.
6Simon LS.Role and regulation of cyclooxygenase-2 during inflammation[J]. Am J Med,1999,106(5B):37s-42s.
7Felson DT, Zhang Y. An update on the epidemiology of knee and hip osteoarthritis with a view to prevention [J] . Arthritis Rheum, 1998, 41(8):1343-1355.
8Hashimoto S, Ochs RL, Rosen F, et al. Chondrocyte- derived apoptotic bodies and calcification of articular cartilage [J]. Proc Natl Acad Sci USA, 1998, 95: 3 094-3 099.
9Kitagawa H, Ujikawa M, Sugahara K. Developmental changes in serum UDP-GlcA: chondroitin glucuronyl- transferase activity[J]. The Journal of Biological Chemistry, 1996, 271:6583-6585.
10Gouze JN, Bianchi A. Glucosamine modulates IL-1-induced activation of rat chondrocytes at a receptor level, and by inhibiting the NF-kB pathway [J]. FEBS Lett, 2002, 510(3) :166-170.
